Top-cited articles

Journal	Paper title	Author
European Heart Journal	Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk	Jean-Claude Tardif
EHJ Quality of Care & Clinical Outcomes	Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation	Linh Ngo
	Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study	Kausik K Ray
	A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999–2018	Safi U Khan
EHJ Cardiovascular Pharmacotherapy	Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study	Philip Sarajlic
	SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis	Roxana Mehran
EHJ Cardiovascular Imaging	Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome	Rebecca T Hahn
	Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis	Gerard T Giblin
	The dysfunctional right ventricle: the importance of multi-modality imaging	Elena Surkova
	Imaging assessment of the right atrium: anatomy and function	Roberto M Lang
European Journal of Preventive Cardiology	Less revascularization in young women but impaired long-term outcomes in young men after myocardial infarction	Anne M Kerola
	Dipping pattern and short-term blood pressure variability are stronger predictors of cardiovascular events than average 24-h blood pressure in young hypertensive subjects	Paolo Palatini
	Light to moderate coffee consumption is associated with lower risk of death: a UK Biobank study	Judit Simon
Cardiovascular Research	Cardiac lipid metabolism, mitochondrial function, and heart failure	Giuseppe Danilo Norata
	Cardiorenal interactions in heart failure – insights from recent therapeutic advances	Kevin Damman
	Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure	Meena S Madhur
European Journal Cardiovascular Nursing	The Core Curriculum for Cardiovascular Nurses and Allied Professionals	Lis Neubeck
	A systematic review, meta-analysis, and meta-regression of patient education for secondary prevention in patients with coronary heart disease: impact on psychological outcomes	Wendan Shi
	Keeping the plates spinning’: a qualitative study of the complexity, barriers, and facilitators to caregiving in heart failure with preserved ejection fraction	Clare R Pearson
	Remote-delivered cardiac rehabilitation during COVID-19: a prospective cohort comparison of health-related quality of life outcomes and patient experiences	Dion Candelaria
EHJ Supplements	Current and future use of neuromodulation in heart failure	David Duncker
	Clinical and radiological factors predicting stroke outcome after successful mechanical intervention in anterior circulation	Tomáš Peisker
EuroIntervention	Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism	Catalin Toma
	Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)	Emanuele Barbato
	Antiplatelet therapy after percutaneous coronary intervention	Dominick J. Angiolillo
	PCI of bystander coronary artery lesions should be performed before TAVI: pros and cons	Ignacio J. Amat-Santos
EJ Heart Failure	TOP 10 CITED AUTHORS
	Myocardial localization of coronavirus in COVID-19 cardiogenic shock	Francesco Mojoli Eloisa Arbustini
	Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society	Alexander R. Lyon
	Epidemiology of heart failure	Amy Groenewegen
	Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure	Biykem Bozkurt
	Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations	Christian Mueller
	Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology	Maria G. Crespo-Leiro
	Treating oxidative stress in heart failure: past, present and future	Peter van der Meer
	Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology	Stefan D. Anker
	2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure	Theresa A. McDonagh Marco Metra
	The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology	Wilfried Mullens
	TOP DOWNLOADED AUTHORS
	Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines	Antoni Bayés-Genís
	Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases	Bettina Heidecker
	Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry	Gianluigi Savarese
	Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial	Javed Butler
	Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy – A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology	Marco Guazzi
	Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology	Massimo F. Piepoli
	Practical outpatient management of worsening chronic heart failure	Nicolas Girerd
	Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON-HF	Scott D. Solomon
	2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure	Theresa A. McDonagh Marco Metra
	Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology	Wilfried Mullens
Open Access journals
EHJ-Case Reports	Fulminant myocarditis following coronavirus disease 2019 vaccination: a case report	Arianne Clare C Agdamag
	A report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination	Christopher Paul Bengel
	Case report of acute myocarditis after administration of coronavirus disease 2019 vaccine in Japan	Masato Ohnishi
EHJ Digital Health	Automated detection of low ejection fraction from a one-lead electrocardiogram: application of an AI algorithm to an electrocardiogram-enabled Digital Stethoscope	Zachi I Attia
	Smartphone as an electronic stethoscope: factors influencing heart sound quality	Hongxing Luo
	Non-invasive detection of cardiac allograft rejection among heart transplant recipients using an electrocardiogram based deep learning model	Demilade Adedinsewo
	Smartwatch-derived heart rate variability: a head-to-head comparison with the gold standard in cardiovascular disease	Fabian Theurl
EHJ Open	Evaluation of the cardiac amyloidosis clinical pathway implementation: a real-world experience	Maaike Brons
	Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries	Robert Edfors
EHJ Imaging Methods and Practice	European Heart Journal—Imaging Methods and Practice (EHJ-IMP): new perspectives, new partnerships, more IMPact	Alessia Gimelli
ESC Heart Failure	TOP CITED AUTHORS
	Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives	Faeq Husain-Syed
	Exercise and heart failure: an update	Gaia Cattadori
	Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies	Heinz-Peter Schultheiss
	Transthyretin cardiac amyloidosis: an update on diagnosis and treatment	Hiroyuki Yamamoto
	Highlights in heart failure	Marco Metra
	Heart failure after myocardial infarction: incidence and predictors	Peter Wohlfahrt
	Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature	Philippe G. Jorens
	Empagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes	Stefan Wagner
	Empagliflozin inhibits Na+/H+ exchanger activity in human atrial cardiomyocytes	Stefan Wagner
	Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study	Tor Biering-Sørensen
	TOP DOWNLOADED AUTHORS
	ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison	Amir Hossein Behnoush, Amirmohammad Khalaji, Haleh Ashraf
	Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials	Amr Abdin
	Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension	Antoni Bayes-Genis
	Vericiguat and NT-proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial	Burkert Pieske
	Obesity and contraceptive use: impact on cardiovascular risk	Giuseppe M.C. Rosano
	Egyptian expert opinion for the use of sodium-glucose cotransporter-2 inhibitors in patients with heart failure with reduced ejection fraction	Magdy Abdelhamid
	Heart failure: an update from the last years and a look at the near future	Marco Metra
	Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care	Marco Metra
	Sodium-glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta-analysis	Subodh Verma
	Prevalence and prognostic impact of cognitive frailty in elderly patients with heart failure: sub-analysis of FRAGILE-HF	Yuya Matsue

Show navigation Hide navigation

Top-cited articles